Introduction
Male circumcision has been practiced for many centuries, with historical record of the procedure going as far back as the late dynastic period of ancient Egypt [1] . Circumcision originated as a religious and symbolic procedure, and medical uses eventually followed [1] . Perhaps because scientific data supporting circumcision arrived somewhat late in the timeline of the procedure and the data often lacked robustness, or perhaps because of its sociopolitical and religious origin, the practice of circumcision has been, and continues to be plagued by controversy. Despite valid concerns from anticircumcision factions, clinical evidence supporting the medical benefits of male circumcision continue to accumulate.
Any review of recent scientific data on the medical benefits of circumcision must mention the three randomized controlled trials conducted in South Africa, Kenya and Uganda that renewed interest in the application of circumcision in disease prevention. These studies randomized men to control and intervention groups and calculated protection against HIV infection, finding the protective effect of male circumcision to be up to 60% [2] [3] [4] . Auvert et al. [3] randomized 3274 uncircumcised men in South Africa aged 18-24 years to immediate or delayed (end of follow-up) circumcision. HIV incidence was 0.85 per 100 person-years in the intervention group and 2.1 per 100 person-years in the control group [relative risk (RR) 0.40, 95% confidence interval (CI) 0.24-0.68%; P < 0.001] [3] . Bailey et al. [4] performed a similar study in Kenya; they randomized 2784 men aged 18-24 to immediate or delayed circumcision. The RR of HIV infection in circumcised men was 0.47 (0.28-0.78) [4] . In Uganda, 4996 uncircumcised, HIV-negative men aged 15-49 years were randomized to immediate or delayed (24 months) circumcision [2] . Over 24 months, HIV incidence was 0.66 cases per 100 person-years in the immediate circumcision group and 1.33 cases per 100 person-years in the delayed circumcision group (estimated efficacy of intervention 51%, 95% CI 16-72; P ¼ 0.006) [2] . These studies confirmed findings of observational studies and led to a recommendation by the WHO to use male circumcision for HIV prevention, along with HIV testing and counseling services, treatment of sexually transmitted infections (STIs), promotion of safer sex habits and correct and consistent condom use [5] . Risk compensation or increased HIV risk behavior was not a significant consequence of circumcision in these trials [6] .
Sexually transmitted infections
Studies on the protective effects of circumcision on STIs followed the HIV prevention trials. Tobian et al. [7 ] randomized 5534 HIV-negative uncircumcised male individuals aged 15-49 years in two trials of male circumcision for the prevention of HIV and other STIs. At 2 years, the cumulative probability of herpes simplex virus type 2 (HSV-2) seroconversion was 7.8% in the intervention group and 10.3% in the control group (adjusted hazard ratio in the intervention group, 95% CI, 0.56-0.92; P ¼ 0.008) [7 ] . The prevalence of high-risk human papillomavirus (HPV) genotypes in the intervention group and control group were 18.0 and 27.9%, respectively (adjusted risk ratio, 0.65; 95% CI, 0.46-0.90; P ¼ 0.009) [7 ] . The incidence of syphilis was not significantly different between the two groups (adjusted hazard ratio, 1.10; 95% CI 0.75-1.65; P ¼ 0.44) [7 ] . cautioned that although significant, the decrease in HPV infections owing to circumcision in these trials is modest, pointing out that the prevalence of HPV in HIV-negative, circumcised men was still greater than 20%, and the prevalence of HPV in HIV-positive, circumcised men was still greater than 55%.
Human papillomavirus
Auvert et al.
[11] reported similar findings on the effect of circumcision on high-risk HPV infections from Orange Farm, South Africa. In an intention-to-treat analysis, the prevalence of high-risk HPV was 14.8% in the intervention group and 22.3% in the control group (prevalence rate ratio of 0.66; 95% CI, 0.51-0.86; P ¼ 0.002).
Hernandez et al. [12] found that although there was no difference in HPV acquisition by circumcision status, clearance of the HPV infection was slower in the glans/coronal sulcus of uncircumcised men compared with circumcised men, 154 days and 91 days, respectively (P ¼ 0.04).
Assessment of implementation
With the identification of circumcision by WHO as a strategy for global HIV prevention, feasibility, safety and cost-effectiveness studies have also been conducted. Implementing large-scale circumcision programs in sub-Saharan Africa will require training programs for a large number of surgeons. Kiggundu et al. [13] used data from their randomized trial in Rakai, Uganda to determine the number of procedures required to achieve optimal competence with male circumcision. During their randomized trial, 3011 men were circumcised using the sleeve method. The mean surgical time was 40 min for the first 100 procedures and declined to 25 min for the subsequent 100 procedures [13] . The rate of adverse events (moderate and severe) was 8.8% for the first 19 unsupervised procedures after training, 4.0% for the next 20-99 procedures and 2.0% for the last 100 (P for trend, 0.003) [13] . [16] . The costs to avert one HIV infection ranged from US$150 to US$900 using a 10-year time horizon [16] . The models also predicted that risk compensation will have only small population level effect [16] . Furthermore, the male circumcision worked synergistically with other HIV prevention strategies, and may indirectly benefit women by reducing HIV prevalence [16] .
Binagwaho et al. [17] performed a cost-effectiveness study of male circumcision in Rwanda. They developed three hypothetical cohorts, newborns, adolescents and adult men, and found that neonatal male circumcision is less expensive than adolescent and adult male circumcision (US$15 vs. US$59 per procedure) and is cost saving. The cost per infection averted was US$3932 for adolescent male circumcision and US$4949 for adult male circumcision [17] . They concluded that Rwanda should scale up circumcision across a broad range of ages, with neonatal circumcision having the most potential to maximize the reduction of HIV incidence [17] .
Sansom et al. [18] addressed a similar question in the USA. They calculated the cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among all males, and found a 15.7% reduction of lifetime HIV risk in the base case analysis, ranging from 7.9% for white men to 20.9% for black men. The net cost of neonatal circumcision per quality-adjusted life years saved was US$87792 for white men [18] . Overall, neonatal circumcision reduced the 1.87% lifetime risk of HIV for all men by 16% [18] .
Out of Africa
Although the three randomized trials conducted in South Africa, Kenya and Uganda reported significant protective effects of male circumcision against HIV infection, how applicable are the results of these trials to men in other parts of the world, with different biological, socioeconomic, cultural and political contexts? Xu et al. [19] posed this very question in the USA. The authors cautioned that there were significant differences between Africa and the USA, such as age at circumcision, dominant mode of HIV transmission, biological factors, HIV transmission dynamics and healthcare system factors [19] . For example, the studies in Africa had a minimum age requirement of 15 years, whereas most American men are circumcised at birth. A direct comparison of the effects of circumcision is difficult to make in these disparate age groups. Another important distinction is the dominant mode of HIV transmission. Whereas heterosexual contact is the most common mode of transmission in the three African countries, penile-anal sexual contact is the most common mode of transmission in the USA [19] . Therefore, the effects of circumcision on male-tomale HIV transmission would be an important component of circumcision policy recommendations in the USA, a transmission mode that was not addressed in the trials in Africa. The effect of circumcision on male-tofemale HIV transmission is another question that remains unanswered.
In the many articles that have been published in the last few years on male circumcision and HIV prevention, one recurring theme is that circumcision programs have the most impact on regions with low circumcision and high-HIV prevalence. Although many countries in subSaharan Africa fit this description, the USA has a relatively high circumcision and low HIV prevalence. HIV prevalence among adults and adolescents in the USA was about 0.14% in 2005 [19, 20] , compared with 6.2-7% in Uganda and Kenya and almost 25% in South Africa [19, 21] . The lower prevalence of HIV in the USA would increase the number of circumcisions needed to avert one new HIV infection and raise the cost per averted infection [19] .
Considerations for circumcision
Not everyone embraces the virtues of circumcision and there are a wide range of opinions and many points of contention. Some circumcision opponents question the removal of healthy tissue rich in nerve-endings and the potential detriment to sexual pleasure. Others dispute the true medical benefits of circumcision, contending that even if it protects against certain infections and diseases, the low incidence (of neonatal urinary tract infections or penile cancer, for example) does not justify the costs of circumcision. As with any surgical procedure, male circumcision has the potential for complications.
Complication rates for circumcision in the three randomized controlled trials in South Africa, Kenya, Uganda ranged from 1.7 to 8% [2] [3] [4] However, complication rates for male circumcision can be much higher, as seen in a study conducted in Bungoma, Kenya: 17.7% among clinical circumcisions (in hospitals, health centers, dispensaries or private clinics) and 35.2% among traditional circumcisions (in villages or household compounds) [22] .
The article by Xu et al. [19] echoed some of the reservations held by the individuals and groups cautioning the implementation of circumcision programs. As discussed previously, the differences between the USA and other developed countries and Africa, where many of the recent studies reporting the benefits of circumcision were conducted, must be assessed before determining health policy. Perhaps the greatest limitations of male circumcision as a prevention strategy are the disappointing results in studies of male-to-female and male-to-male HIV and STI transmission.
The data demonstrating the protective effects of male circumcision in high-HIV prevalence regions in Africa are strong, and circumcision programs as part of a broader strategy along with counseling services, safe sex education and testing and treating for STIs and HIV will play an important role in Africa. With the increased media interest generated by positive results of recent studies, Wang et al. [23] assessed the content and accuracy of print media reports on male circumcision for preventing HIV infection among men in sub-Saharan Africa. They identified 15 key messages from the WHO-UNAIDS Montreux recommendations and a supplementary legal and ethical guidance document and found that the accuracy of the reports was good, but were few in number and often omitted important messages [23] [24] [25] . See the list below:
Key messages on male circumcision for preventing HIV infection. Reprint of box 1 in [23] :
(1) HIV testing is recommended for all men seeking male circumcision. (2) Male circumcision should be provided after informed consent, with confidentiality and without coercion or discrimination. Adapted from WHO-UNAIDS recommendations and a supplementary ethical and legal guidance document.
Interestingly, although the majority (56%) of articles were positive in their portrayal of circumcision, the negative articles were repeated 2.9 times more often, perhaps indicating the media's inclination for covering controversial viewpoints [23] .
Conclusion
Male circumcision has been performed for many centuries. Although health benefits have been reported for many years, circumcision has once again garnered attention as a critical public health initiative. Circumcision appears to protect against certain STIs in addition to HIV and will likely be an integral part of HIV prevention programs in Africa. The broader application of this procedure to other areas of the world with different population, infrastructure and disease characteristics warrants further investigation.
